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Examination of Hardy-Weinberg equilibrium in papers of
Kidney International: An underused tool.
Background. Population-genetic studies investigating ge-
netic polymorphisms of Mendelian inheritance should always
test whether the measured genotype frequencies deviate from
the expected one. For this purpose Hardy-Weinberg (HW) crite-
ria are generally used. If genotype distribution of control pop-
ulation misses HW equilibrium, the results should be treated
cautiously because the observed genotype distribution in con-
trol population does not represent genotype distribution in the
overall population. If HW criteria are not fulfilled in the inves-
tigated population, this may be further evidence for the corre-
lation between genotype and investigated condition.
Methods. Between September, 1998, and September, 2003,
we tested papers published in Kidney International if HW crite-
ria were ordinarily and correctly checked in studies investigat-
ing genetic polymorphisms. Seventy-five genotype distributions
of the selected 39 articles were reanalyzed.
Results. HW calculation was reportedly performed in 25 pa-
pers (64%). The observed genotype distribution deviated signif-
icantly from the expected one in three control, and in 16 patient
populations and in three populations of association studies of
15 papers overall; however, this fact was not mentioned in 12
papers.
Conclusion. Although the deviation of genotype distribution
from the expected one is important information, HW calcula-
tions are not performed routinely for each investigated subject
groups in these papers investigating genetic polymorphisms.
During the past decade the association of genetic poly-
morphisms with the risk and development of renal dis-
eases has been extensively studied. According to the
PubMed database, more than 1300 papers containing the
key words “human kidney” and “genetic polymorphism”
had been published by November 2003.
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A significant part of these studies investigates biallelic
genetic polymorphisms of Mendelian inheritance. While
the accuracy of laboratory methods is excellent, popula-
tion genetic studies may be still biased by other points
of methodology, especially by the selection of subjects. If
genotype distribution of enrolled groups is skewed and
this fact remains undetected, the drawn conclusions are
possibly biased. Population-genetic studies should there-
fore always test whether measured genotype frequencies
deviate significantly from the expected one. For this pur-
pose the Hardy-Weinberg (HW) criteria are generally
used [1–6]. However, according to our personal experi-
ence, data about HW calculations in the studied popula-
tions are not always presented, or HW values are often
miscalculated. Between 1998 and 2003, in this retrospec-
tive survey we tested papers published in Kidney In-
ternational if HW criteria were ordinarily and correctly
checked in studies investigating genetic polymorphisms.
METHODS
Subjects and methods
Using the Medline Database we selected 103 pa-
pers from past issues of Kidney International, which re-
ports laboratory data about population genetics. Detailed
genotype distribution was presented in 39 papers.
Data analysis
We systematically reviewed these articles, and two in-
dependent observers recalculated Hardy-Weinberg equi-
librium in each paper in each study group. For this
purpose the Arlequin software (http://anthro.unige.ch/
arlequin/) was used [7]. The level of statistical significance
was set at P < 0.05. Deviations from HW equilibrium
were confirmed by manual recalculation.
We also tested whether authors calculated HW cri-
teria and presented any data about the results of their
calculations.
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Table 1. Summary of papers with unreported Hardy-Weinberg (HW) values under P = 0.05
Genotype distribution
Reference AA AB BB Total no. of subjects Affected population Investigated polymorphism HW, P value
17 3 87 169 259 Association study AGT-235 0.028
8 8 22 0 30 Patient TGF-b1 codon10 0.009
10 31 132 173 Control TNF-a -308 0.001
13 85 37 11 133 Patient COLIA 1 0.041
10 2 5 17 Patient COLIA 1 0.003
11 24 24 17 65 Patient TGF-b1 codon10 0.045
18 66 125 109 300 Association study IL-10–1082 0.009
12 16 27 0 43 Patient TGF-b1–509 0.016
13 27 3 43 Patient TGF-b1 codon10 0.052
15 10 29 3 42 Patient GLUT-1 (XbaI-) 0.011
9 29 123 68 220 Control VDR BsmI 0.027
19 46 27 12 85 Association study MTFR–677 0.036
16 43 78 10 131 Patient GLUT-1 (XbaI-) 0.002
12 48 4 64 Patient GLUT-1 (XbaI-) 0.001
14 64 116 28 208 Patient PAI-1 0.047
42 88 22 152 Patient PAI-1 0.031
28 58 12 98 Patient PAI-1 0.036
10 19 48 8 75 Control ACE I/D 0.009
For abbreviations of affected mutations see original articles. HW, P value: observed vs. calculated expected frequencies.
RESULTS
Finally, 75 genotype distributions of the selected 39 arti-
cles were reanalyzed. HW calculation was reportedly per-
formed in 25 papers (64%). According to our calculation,
the genotype distribution deviated significantly from the
expected one in three reference populations in 16 patient
populations and in 3 populations of association studies al-
together in 15 papers. However, this fact was mentioned
in only three papers. The authors of five articles stated
that HW criteria are fulfilled, in spite of the presence of
significant deviations of genotype distributions. For fur-
ther details see Table1.
DISCUSSION
HW values do have profound effects on the possible
conclusions that could be drawn from a population-
genetic study. If genotype distribution misses HW
equilibrium in controls, the results should be treated
cautiously because the observed genotype distribution
in the reference (non-diseased) population does not rep-
resent the genotype distribution in healthy people. This
bias was present in three papers. Therefore, it needs fur-
ther studies with new reference groups to investigate
the association between tumor necrosis factor-a (TNF-a)
−308 polymorphism and renal function after transplan-
tation [8], VDR BsmI polymorphism, and severity of hy-
perparathyroidism in patients on dialysis [9], ACE I/D
polymorphism, and essential hypertension or nephroan-
giosclerosis [10].
If HW criteria are not fulfilled in the investigated (dis-
eased) population, this might be further evidence for the
correlation between genotype and disease (as in 13 of
reanalyzed papers). Even in the absence of significant
difference between genotype frequencies, unreported or
weak associations could be detected by calculating the
HW equilibrium. However, our results suggest that this
analytical tool is largely underused; 18% of the 39 reana-
lyzed studies did not recognize the abnormal distribution
of genotype in patient population.
Melk et al [8], Wong et al [11], and Cotton et al [12]
did not notice that genotype distributions of transforming
growth factor-b1 (TGF-b1) polymorphisms were out of
HW equilibrium in transplanted patients with stable re-
nal function, in patients with diabetic nephropathy, and
in patients with renal parenchymal scarring, respectively.
The distribution of COLIA polymorphism was skewed in
patients with osteoporotic men [13]. Genotype distribu-
tions of PAI and GLUT-1 polymorphisms did not fulfill
HW criteria in patients with diabetic nephropathy [14–
16].
Although the conclusions of these studies are proba-
bly correct, the unreported deviations of genotype dis-
tributions would have provided additional supporting
evidence for the observed associations between genotype
and disease.
When the impact of genotype on continuous variables
and/or disease state is investigated in association studies,
the fulfilment of HW criteria is not a must. However, we
are convinced that the significant deviation of the geno-
type distribution is also worth mentioning in these re-
ports, especially when the enrolled subjects are randomly
selected from a larger population (as in three papers [17–
19]).
CONCLUSION
Interestingly, the authors stated that genotype distri-
bution data fulfilled HW criteria in five of the affected
papers. Indeed, this statement was established for the
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reference, but not for the patient groups. Probably in
these cases HW values were not calculated for each
genotype distributions in each subgroup of subjects in
the study. This finding urges that the numeric results of
HW calculations for each investigated subject groups be
presented instead of the general statement that “geno-
type distribution fulfilled HW criteria.” The discrep-
ancy between published and recalculated HW values also
suggests that rechecking some papers’ HW calculations
might be of value for the interested readers. Unfortu-
nately, many reports publish exclusively allele frequen-
cies, and state the fulfillment of HW criteria without
detailed presentation of genotype frequencies. There-
fore, it is highly recommended for the authors to pub-
lish the prevalence of each genotype together with allele
frequencies.
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